Parkinson's patients 'walk and talk again' after receiving cancer drug in trial
Professor who led the study says 'we've seen patients at end stages of the disease coming back to life'
lunes, 19 de octubre de 2015
Ensayo clínico para Enfermedad de Huntington
Landmark Huntington's trial starts.
The first drug that can potentially correct the underlying defect that causes Huntington's disease has been taken by patients in a clinical trial.
BBC.
Via: Bionews.
The first drug that can potentially correct the underlying defect that causes Huntington's disease has been taken by patients in a clinical trial.
BBC.
Via: Bionews.
Suscribirse a:
Entradas (Atom)